GNI Group Ltd. (2160)

Market cap
¥174.3B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Dec 31, 20255,717+0.36%
Dec 31, 20245,696+8.74%
Dec 31, 20235,239+32.58%
Dec 31, 20223,951+34.23%
Dec 31, 20212,944+21.38%
Dec 31, 20202,425+1.05%
Dec 31, 20192,400+25207.77%
Dec 31, 20189+3.49%
Dec 31, 20179-13.69%
Dec 31, 201611-13.22%
Dec 31, 201512-11.36%
Dec 31, 201414
AI Chat